Instalab
logoInstalab

Elm Tree IgE

See whether elm pollen is driving your seasonal sneezing, itchy eyes, or asthma flares.
4.8 (4,440 reviews)
Tested by Diagnostic Solutions Lab
Physician-reviewed results
How it works
Order from Instalab
No prescription or your own doctor's order needed
Get blood drawn
At home
Get results
Explained with clear next steps, no medical jargon

Should you take a Elm Tree IgE test?

This test is most useful if any of these apply to you.

Sneezing Through Spring
If your symptoms peak in late winter or early spring, this test can pinpoint whether elm pollen is part of the trigger pattern.
Living With Allergic Asthma
If your asthma worsens during tree pollen season, identifying elm sensitization helps you anticipate flares and adjust treatment.
Parenting a Child With Pollen Allergies
Children in tree-heavy regions often develop sensitization to early-spring pollens like elm, and testing maps their specific triggers.
Considering Allergy Shots
Before starting immunotherapy, you need a clear sensitization profile across tree pollens to choose the right treatment plan.

About Elm Tree IgE

If your nose runs, your eyes itch, or your chest tightens during spring, you want to know exactly which pollen is doing it. Elm trees release pollen earlier than most other trees, often before people even think allergy season has started, and a blood test for elm-specific IgE can tell you whether your immune system has flagged elm as a threat.

This is one of the more nuanced allergy markers to interpret. A positive result does not always mean true elm allergy, and a negative result on broader screening labs does not always rule it out. Knowing how to read the number, and what to pair it with, makes the difference between a clear answer and a confusing one.

What This Test Actually Measures

The test measures IgE (immunoglobulin E), a class of antibody your immune system produces when it identifies a normally harmless substance as a threat. Specifically, it measures IgE that binds to elm pollen proteins. These antibodies are made by B cells (a type of white blood cell) that have switched their output to IgE after being exposed to elm pollen, often through the lining of the nose, eyes, and airways.

When you encounter elm pollen again, those IgE antibodies sit on mast cells (immune cells that store inflammatory chemicals) and trigger the release of histamine and other compounds, producing the symptoms you recognize as allergy. A measurable level of elm-specific IgE in your blood means you are sensitized. Whether that sensitization causes actual symptoms depends on your exposure and how your body responds in real time.

Why Elm Specifically Matters

Elm is one of the more common airborne pollens in regions where elm trees grow, and it is a documented driver of childhood respiratory allergies. In a study of children with respiratory allergic disease, elm sensitization was identified among the critical pollens, alongside Bermuda grass, birch, and mugwort, contributing to symptom flares during pollen peaks.

Sensitization to multiple pollens is the rule rather than the exception. In a study of 500 allergic patients, 81% were sensitized to more than one allergen, and the more pollens a person reacted to, the more severe their rhinitis and asthma symptoms tended to be. Knowing whether elm is on your list helps map your full pollen exposure profile.

Allergic Rhinitis and Asthma

Sensitization to tree pollens, including elm, is strongly tied to allergic rhinitis (the medical name for hay fever) and to a lesser degree asthma. In a New York City birth cohort study, children living near higher urban tree canopy had more tree pollen sensitization (using a panel that included American elm) and more asthma at age 7 than children in less tree-dense areas.

A hospital-based case-control study of nearly 13,000 people in China found that the more allergens a person was sensitized to, the higher their risk of allergic disease. Elm-specific IgE adds one more piece to that picture. If your symptoms cluster around elm pollen season (typically late winter to early spring), confirming sensitization helps you act on the timing rather than guess.

When Total IgE Misses the Story

A common assumption is that if your total IgE level is normal, you do not have meaningful allergies. Elm is one of the pollens that breaks this rule. In a five-year retrospective study of 7,654 atopic patients (people with an inherited tendency to develop allergic conditions), 22.8% had both normal total IgE and normal eosinophil counts (a type of allergy-related white blood cell) yet still tested positive for specific allergens. Sensitizations to willow, aspen, and elm were over-represented in this group.

The takeaway: a normal total IgE does not exclude elm sensitization. If your symptoms point toward early spring tree pollens, a specific elm IgE test gives you information that broader screens may miss.

Why a Positive Result Is Not Always a True Allergy

Some elm IgE positives are not really about elm. The reason is something called CCDs (cross-reactive carbohydrate determinants), which are sugar groups attached to many plant proteins. Your immune system can make IgE against these sugars rather than against elm itself, and that IgE then binds to many different pollen extracts in the lab, producing false positives across the board.

In a South China study of patients with multi-allergen sensitization, IgE to a tree pollen mix that included elm turned out to be driven by CCDs in many cases. After the lab added a CCD inhibitor (a substance that blocks IgE from binding to these sugars), 73% of tree pollen positives became negative. A separate study confirmed similar drops in tree pollen IgE after CCD inhibition, with results aligning more closely with actual symptoms.

This means a positive elm IgE on a basic panel may need follow-up. If your number is high but you have no symptoms during elm pollen season, ask whether CCD inhibition or component-resolved testing (a method that identifies which exact protein your IgE binds to) was used.

Reference Ranges

Elm-specific IgE is reported in kUA/L (a unit of antibody concentration). The traditional cutoff for sensitization is 0.35 kUA/L, but research suggests this threshold catches some people whose positive result does not reflect true clinical allergy. A study of 300 school-age children found that 0.75 kUA/L was a more accurate cutoff for several common aeroallergens, with thresholds varying by allergen. These ranges come from broader aeroallergen research rather than elm-specific cohorts, so treat them as orientation rather than firm clinical targets. Different labs may use different assay platforms (ImmunoCAP and Immulite are the two most common), and results between platforms do not always align perfectly.

TierRange (kUA/L)What It Suggests
NegativeLess than 0.35No detectable sensitization to elm pollen
Low positive0.35 to 0.74Sensitization detected, but may not always reflect true clinical allergy; consider symptoms and CCD interference
Clear positive0.75 or higherSensitization more likely to correspond with symptoms during elm pollen season

Compare your results within the same lab over time, since assay differences between labs can shift the absolute number. The most important interpretation question is not which range you fall into, but whether your number tracks with your real-world symptoms during elm pollen season.

When Results Can Be Misleading

Three common factors can distort how you interpret a single elm IgE reading.

  • CCD interference: sugar-based cross-reactivity can produce false-positive elm IgE in patients without true elm allergy; in one study, 73% of tree pollen positives reverted to negative after the lab applied a CCD inhibitor.
  • Cross-reactivity with other plants: if you are allergic to birch, grass, or other tree pollens, you may show a positive elm IgE from shared protein families (profilins and PR-10 proteins, which appear across many plant species), even if elm itself is not your real trigger.
  • Dupilumab and omalizumab use: these biologic medications used for severe allergy and asthma can lower total IgE and may affect specific IgE measurements. If you are on either, mention it before testing.
  • Sampling outside pollen season: elm IgE levels can show seasonal variation; testing well after pollen exposure may give a different reading than testing during peak season.

Tracking Your Trend

A single elm IgE number is a snapshot. Sensitization can rise as exposure accumulates, fall over time as you age, or shift if you start an allergy treatment. A study tracking pollen IgE across 7 years documented cyclic seasonal variation, meaning the same person can have meaningfully different numbers depending on when blood is drawn relative to pollen season.

Get a baseline ideally before or during the spring tree pollen season. If you start allergen immunotherapy (allergy shots or sublingual tablets), retest at 6 to 12 months to track immunologic changes. Otherwise, an annual recheck is reasonable, especially if your symptoms change or you move to a new region with different pollen exposure.

If Your Result Is Positive: What to Do Next

A positive elm IgE on its own is not enough to drive treatment decisions. Pair it with the following:

  • A symptom diary: track when you sneeze, cough, or wheeze, and check whether those days line up with local elm pollen counts.
  • A broader pollen panel: elm rarely travels alone; testing for birch, oak, maple, and grass pollens helps map your full sensitization profile and informs whether immunotherapy makes sense.
  • Component-resolved diagnostics or CCD inhibition: if your elm IgE is elevated but symptoms do not match, ask an allergist about advanced molecular testing to distinguish true elm allergy from cross-reactivity.
  • An allergist consultation if symptoms are significant: a specialist can confirm whether elm is a true clinical trigger and discuss whether allergen immunotherapy (the only treatment that modifies the underlying immune response) is appropriate.

If your symptoms are mild and your elm IgE is low, antihistamines and intranasal steroids during elm season may be all you need. If your IgE is high and your symptoms are disrupting daily life, an allergist workup is the next step.

What Moves This Biomarker

Evidence-backed interventions that affect your Elm Tree IgE level

↓ Decrease
Omalizumab (anti-IgE biologic) for allergic rhinitis or asthma
Omalizumab is a biologic medication that binds free IgE in the blood, reducing the IgE available to trigger allergic reactions. A meta-analysis confirmed it improves symptoms, quality of life, and reduces rescue antihistamine use in allergic rhinitis. A randomized trial of 536 adults with seasonal allergic rhinitis found omalizumab dose-dependently reduced nasal symptoms. Because omalizumab lowers measurable free IgE, it can also alter specific IgE readings while you are on therapy, so interpret elm IgE results with caution if you are receiving treatment.
MedicationStrong Evidence
↕ Up & Down
Allergen-specific immunotherapy (allergy shots or sublingual tablets) for tree pollens
Allergen immunotherapy is the standard treatment that targets the underlying immune response in pollen allergy. Specific IgE typically rises in the first months of treatment, then gradually falls and shifts toward a more tolerant immune profile over years. A subcutaneous immunotherapy trial in local allergic rhinitis with grass pollen extract showed that immunotherapy is safe and effective for pollen-driven symptoms, with broader reviews indicating that 3 to 4 years of treatment can produce prolonged clinical remission and lasting changes in immunologic reactivity. Direct elm-specific data are limited, so effects are inferred from related tree pollen immunotherapy.
MedicationModerate Evidence
↑ Increase
High-tree-canopy urban environment exposure during childhood
Higher urban tree canopy coverage was associated with greater prevalence of allergic sensitization to tree pollen (using a panel that included American elm) at age 7 in a New York City birth cohort of 549 children. The same study found tree canopy was not protective against asthma or allergy outcomes overall. Greater pollen exposure during childhood can drive sensitization that persists into adulthood, making elm IgE more likely to be elevated.
LifestyleModerate Evidence
↓ Decrease
Probiotic supplementation in early childhood
A meta-analysis of clinical trials found that probiotic administration in early life reduces the risk of atopic sensitization and lowers total IgE levels in children. Effects on elm-specific IgE were not directly measured. Probiotics did not significantly reduce asthma or wheeze risk in this analysis. This is most relevant for primary prevention in children rather than a treatment for established adult elm sensitization.
SupplementModest Evidence

Frequently Asked Questions

References

21 studies
  1. Chen H, Jiang Q, Yang Y, Zhang W, Yang L, Zhu RJournal of Asthma and Allergy2022
  2. Zhao L, Wu Y, Zhu H, Lin Y, Su H, Hu J, Zhang M, Bao WJournal of Asthma and Allergy2025
  3. Lovasi G, O'neil-dunne J, Lu JWT, Sheehan DW, Perzanowski M, Macfaden S, King KL, Matte T, Miller RL, Hoepner LA, Perera F, Rundle aEnvironmental Health Perspectives2013
  4. Xu L, Dai Y, Luo W, Jiang W, Tan Q, Lu Y, Huang Z, Gu W, Li P, Wang P, Huang L, Sun H, Hao C, Sun BJournal of Asthma and Allergy2024